3D-FS33335 - stilbene-44-dicarboxylic-acid
Lo sentimos, no se ha encontrado ningún producto con referencia 3D-FS33335, pero quizás quiera comprobar los siguientes productos similares:
3,3 DIMETHYL CIS 1,2 CYCLOPROPANE DICARBOXYLIC ACID
CAS:Fórmula:C7H10O4Pureza:98%Forma y color:SolidPeso molecular:158.1519cis-1,2-Cyclopropane dicarboxylic acid
CAS:Fórmula:C5H6O4Pureza:97%Forma y color:SolidPeso molecular:130.0987Febuxostat dicarboxylic acid impurity
CAS:Febuxostat dicarboxylic acid impurityPureza:≥95%Peso molecular:335.38g/molFebuxostat dicarboxylic acid impurity
CAS:Febuxostat dicarboxylic acid impurity is an impurity of Febuxostat. Febuxostat is selective xanthine oxidase inhibitor with a K i of 0.6 nM [1] .Fórmula:C16H17NO5SForma y color:SolidPeso molecular:335.38Malathion dicarboxylic acid
CAS:Fórmula:C6H11O6PS2Forma y color:Colourless CrystallinePeso molecular:274.25Perfluoropolyether dicarboxylic acid
Perfluoropolyether dicarboxylic acidPureza:≥95%Forma y color:LiquidAcetylene dicarboxylic acid potassium salt
CAS:Acetylene dicarboxylic acid potassium salt (ADAC) is a drug that belongs to the class of 2-fluorobenzoic acid derivatives. Acetylene dicarboxylic acid potassium salt inhibits the enzyme 2,3-dihydroxybenzoate-4-hydroxylase and reduces the production of propiolic acid, which leads to a decrease in the synthesis of tetracene. Acetylene dicarboxylic acid potassium salt has been shown to be an effective anesthetic, with good visual and motor activity. The high toxicity of this compound is due to its high affinity for protein binding sites and its ability to form hydrogen bonds.Fórmula:C4H2KO4Pureza:Min. 95%Peso molecular:153.15 g/mol2,3-Pyrazine dicarboxylic acid
CAS:Fórmula:C6H4N2O4Pureza:98%Forma y color:SolidPeso molecular:168.1082,3-Pyridine dicarboxylic acid
CAS:Fórmula:C7H5NO4Pureza:98%Forma y color:Solid, Light yellow powderPeso molecular:167.12Bicyclo[2.2.2] octane-1,4 dicarboxylic acid
CAS:Fórmula:C10H14O4Pureza:97%Forma y color:SolidPeso molecular:198.218Bifendate Dicarboxylic Acid
CAS:Producto controladoApplications Carboxylic acid derivative of Bifendate (B382890), a synthetic intermediate of Schisandrin C and also a anti-HBV drug used in the treatment of chronic hepatitis B.
References Pan, S.Y., et al.: Euro. J. Pharmacol. 522, 170 (2006); Zeng, Y., et al.: Acta. Pharmacol. Sinica., 30, 478 (2009);Fórmula:C18H14O10Forma y color:NeatPeso molecular:390.3Cabastine Hydrochloride Dicarboxylic Acid
Producto controladoFórmula:C26H31ClFNO4•(HCl)Forma y color:NeatPeso molecular:511.169244,5-Disulfo Rhodamine-123 Dicarboxylic Acid Lithium Salt(Mixture of isomers, Technical Grade)
CAS:Producto controladoStability Light Sensitive
Applications 4,5-Disulfo Rhodamine-123 dicarboxylic acid is a xanthene dye substituted two times by a sulfonic acid used as fluorescent probes, particularly in biological samples. It is more photostable than fluorescein.
References Stenman, U., et al.: Cancer Res., 51, 222 (1991), Mitrunen, K., et al.: Clin. Chem., 41, 1115 (1995), Karvinen, J., et al.: Anal. Biochem., 325, 317 (2004), Hemmila, I., et al.: J. Fluoresc., 15, 529 (2005),Fórmula:C22H16Li2N2O11S2Forma y color:NeatPeso molecular:562.37Montelukast dicarboxylic acid
CAS:Producto controladoMontelukast is a drug product that belongs to the class of drugs called leukotriene receptor antagonists. Montelukast binds to cysteinyl leukotrienes (LTC4, LTD4, LTE4) and prevents their interaction with receptors on the cell surface. It can be used for the treatment of asthma, chronic obstructive pulmonary disease, and other allergic conditions. Montelukast is available in tablet form and is taken orally. Montelukast is not expected to be toxic because it has been shown to have a low incidence of side effects in clinical trials.Fórmula:C35H34ClNO5SPureza:Min. 95%Peso molecular:616.20 g/molDimethyl 1,2,3,4-tetrahydronaphthalene-2,6-dicarboxylate
CAS:Fórmula:Pureza:≥95%Peso molecular:248.27Ref: BD-BD434832
1gA consultar
![Bicyclo[2.2.2] octane-1,4 dicarboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF051075.webp&w=3840&q=75)
